XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.631
-0.000 (-0.03%)
At close: Dec 5, 2025, 4:00 PM EST
0.620
-0.011 (-1.73%)
After-hours: Dec 5, 2025, 5:47 PM EST
XORTX Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 1.75 | 2.19 | 2.28 | 1.93 | 1.22 | 0.4 | |
| Research & Development | 0.53 | 0.18 | 2.42 | 6.76 | 0.68 | 0.22 | |
| Amortization of Goodwill & Intangibles | 0.03 | 0.03 | 0.07 | 0.02 | 0.01 | 0.02 | |
| Operating Expenses | 2.42 | 2.62 | 4.96 | 9.24 | 2.31 | 0.87 | |
| Operating Income | -2.42 | -2.62 | -4.96 | -9.24 | -2.31 | -0.87 | |
| Interest Expense | - | - | - | - | -0 | -0.01 | |
| Interest & Investment Income | 0.06 | 0.12 | 0.25 | 0.1 | - | - | |
| Currency Exchange Gain (Loss) | -0.06 | -0.07 | -0.01 | -0 | -0.01 | 0 | |
| Other Non Operating Income (Expenses) | 0.47 | -0.75 | 2.55 | 1.42 | 0.75 | -0.16 | |
| EBT Excluding Unusual Items | -1.94 | -3.31 | -2.16 | -7.72 | -1.58 | -1.03 | |
| Asset Writedown | - | - | - | - | - | -0.05 | |
| Other Unusual Items | - | - | - | - | - | 0.07 | |
| Pretax Income | -1.94 | -3.31 | -2.16 | -7.72 | -1.58 | -1.01 | |
| Net Income | -1.94 | -3.31 | -2.16 | -7.72 | -1.58 | -1.01 | |
| Net Income to Common | -1.94 | -3.31 | -2.16 | -7.72 | -1.58 | -1.01 | |
| Shares Outstanding (Basic) | 4 | 3 | 2 | 1 | 1 | 1 | |
| Shares Outstanding (Diluted) | 4 | 3 | 2 | 1 | 1 | 1 | |
| Shares Change (YoY) | 53.07% | 45.25% | 33.91% | 35.25% | 47.77% | 24.34% | |
| EPS (Basic) | -0.50 | -1.15 | -1.09 | -5.22 | -1.44 | -1.36 | |
| EPS (Diluted) | -0.50 | -1.15 | -1.09 | -5.22 | -1.44 | -1.36 | |
| Free Cash Flow | -2.95 | -3.68 | -6.59 | -8.19 | -4.8 | -0.57 | |
| Free Cash Flow Per Share | -0.75 | -1.28 | -3.32 | -5.53 | -4.39 | -0.77 | |
| EBITDA | -2.44 | -2.58 | -4.88 | -9.22 | -2.3 | -0.85 | |
| D&A For EBITDA | -0.03 | 0.04 | 0.07 | 0.02 | 0.01 | 0.02 | |
| EBIT | -2.42 | -2.62 | -4.96 | -9.24 | -2.31 | -0.87 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.